Successful treatment of severe hepatic impairment in erythropoietic protoporphyria: A case report and review of literature.

IF 2.5 Q2 GASTROENTEROLOGY & HEPATOLOGY
Tao Zeng, Shu-Ru Chen, Hao-Qiang Liu, Yu-Tian Chong, Xin-Hua Li
{"title":"Successful treatment of severe hepatic impairment in erythropoietic protoporphyria: A case report and review of literature.","authors":"Tao Zeng, Shu-Ru Chen, Hao-Qiang Liu, Yu-Tian Chong, Xin-Hua Li","doi":"10.4254/wjh.v16.i6.966","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Erythropoietic protoporphyria (EPP) is a rare genetic disorder stemming from ferrochelatase gene mutations, which leads to abnormal accumulation of protoporphyrin IX primarily in erythrocytes, skin, bone marrow and liver. Although porphyria-related severe liver damage is rare, its consequences can be severe with limited treatment options.</p><p><strong>Case summary: </strong>This case study highlights a successful intervention for a 35-year-old male with EPP-related liver impairment, employing a combination of red blood cell (RBC) exchange and therapeutic plasma exchange (TPE). The patient experienced significant symptom relief and a decrease in bilirubin levels following multiple PE sessions and an RBC exchange.</p><p><strong>Conclusion: </strong>The findings suggest that this combined approach holds promise for managing severe hepatic impairment in EPP.</p>","PeriodicalId":23687,"journal":{"name":"World Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11212650/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4254/wjh.v16.i6.966","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Erythropoietic protoporphyria (EPP) is a rare genetic disorder stemming from ferrochelatase gene mutations, which leads to abnormal accumulation of protoporphyrin IX primarily in erythrocytes, skin, bone marrow and liver. Although porphyria-related severe liver damage is rare, its consequences can be severe with limited treatment options.

Case summary: This case study highlights a successful intervention for a 35-year-old male with EPP-related liver impairment, employing a combination of red blood cell (RBC) exchange and therapeutic plasma exchange (TPE). The patient experienced significant symptom relief and a decrease in bilirubin levels following multiple PE sessions and an RBC exchange.

Conclusion: The findings suggest that this combined approach holds promise for managing severe hepatic impairment in EPP.

成功治疗红细胞生成性原卟啉症的严重肝功能损害:病例报告和文献综述。
背景:红细胞生成性原卟啉症(Erythropoietic protoporphyria,EPP)是一种罕见的遗传性疾病,源于铁螯合酶基因突变,导致原卟啉 IX 主要在红细胞、皮肤、骨髓和肝脏中异常积聚。虽然与卟啉症相关的严重肝损伤很少见,但其后果可能很严重,而且治疗方案有限。病例摘要:本病例研究重点介绍了对一名患有 EPP 相关肝损伤的 35 岁男性患者采取的成功干预措施,该措施采用了红细胞(RBC)交换和治疗性血浆交换(TPE)相结合的方法。经过多次治疗性血浆置换和一次红细胞置换后,患者的症状明显缓解,胆红素水平也有所下降:结论:研究结果表明,这种联合方法有望治疗 EPP 中的严重肝功能损害。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
World Journal of Hepatology
World Journal of Hepatology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
4.10
自引率
4.20%
发文量
172
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信